Citations 4
Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis
Arkenau, Hendrik‐Tobias , Kubicka, Stefan, Seufferlein, Thomas , Reichardt, Peter , Freier, Werner , Porschen, Rainer, Schmoll, Hans‐Joachim , Graeven, Ullrich , Grothey, Axel
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3546-3546
Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis
Arkenau, Hendrik‐Tobias , Kubicka, Stefan, Kretzschmar, Albrecht , Freier, Werner , Seufferlein, Thomas , Hinke, Axel , Porschen, Rainer, Schmoll, Hans‐Joachim , Graeven, Ullrich , Grothey, Axel
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3507-3507
In Reply
Porschen, Rainer, Arkenau, Hendrik‐Tobias , Kubicka, Stefan, Greil, Richard , Seufferlein, Thomas , Freier, Werner , Kretzschmar, Albrecht , Hinke, Axel , Schmiegel, Wolff , Graeven, Ullrich , Grothey, Axel , Schmoll, Hans‐Joachim
Journal of Clinical Oncology | October 30, 2007 | Volume: 25 | Issue: 31 | Pages: 5042-5043
In Reply
Porschen, Rainer, Arkenau, Hendrik‐Tobias , Kubicka, Stefan, Greil, Richard , Seufferlein, Thomas , Freier, Werner , Kretzschmar, Albrecht , Hinke, Axel , Schmiegel, Wolff , Graeven, Ullrich , Grothey, Axel , Schmoll, Hans‐Joachim
Journal of Clinical Oncology | October 30, 2007 | Volume: 25 | Issue: 31 | Pages: 5045-5046